PF-06807656

N/A

Report date: 2022/05/24 15:09:17
NME

Base Information

Drug NamePF-06807656
Drug Alias NamePF-06807656
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionATP-sensitive inward rectifier potassium channel 1 inhibitors
TargetsATP-sensitive inward rectifier potassium channel 1
Therapy Area/IndicationsHypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A